# Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives

**Authors:** Camilla Steen Jensen, Steen Gregers Hasselbalch, Gunhild Waldemar, Anja Hviid Simonsen

PMC · DOI: 10.3389/fneur.2015.00187 · 2015-08-26

## TL;DR

This review explores how physical exercise affects biochemical markers in people with mild cognitive impairment or dementia.

## Contribution

The study systematically reviews the biochemical effects of physical exercise in MCI and dementia patients.

## Key findings

- Seven out of eight studies showed positive effects of exercise on biomarkers like brain-derived neurotrophic factor and cholesterol.
- Exercise was associated with changes in testosterone, estradiol, dehydroepiadrosterone, and insulin levels.
- More research is needed to understand the biochemical impact of physical exercise on cognitive disorders.

## Abstract

The cognitive effects of physical exercise in patients with dementia disorders or mild cognitive impairment have been examined in various studies; however the biochemical effects of exercise from intervention studies are largely unknown. The objective of this systematic review is to investigate the published results on biomarkers in physical exercise intervention studies in patients with MCI or dementia.

The PubMed database was searched for studies from 1976 to February 2015. We included intervention studies investigating the effect of physical exercise activity on biomarkers in patients with MCI or dementia.

A total of eight studies were identified (n = 447 patients) evaluating exercise regimes with variable duration (single session–three sessions/week for 26 weeks) and intensity (light-resistance training–high-intensity aerobic exercise). Various biomarkers were measured before and after intervention. Seven of the eight studies found a significant effect on their selected biomarkers with a positive effect of exercise on brain-derived neurotrophic factor, cholesterol, testosterone, estradiol, dehydroepiadrosterone, and insulin in the intervention groups compared with controls.

Although few studies suggest a beneficial effect on selected biomarkers, we need more knowledge of the biochemical effect of physical exercise in dementia or MCI.

## Linked entities

- **Chemicals:** cholesterol (PubChem CID 5997), testosterone (PubChem CID 6013), estradiol (PubChem CID 450), insulin (PubChem CID 70678557)
- **Diseases:** dementia (MONDO:0001627)

## Full-text entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SHBG (sex hormone binding globulin) [NCBI Gene 6462] {aka ABP, SBP, TEBG}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], sAA [NCBI Gene 6287], IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225]
- **Diseases:** Dementia (MESH:D003704), amyloid (MESH:C000718787), Inflammation (MESH:D007249), mental disorders (MESH:D001523), memory deficiencies (MESH:D008569), diabetes (MESH:D003920), metabolic impairments (MESH:D008659), neurotoxicity (MESH:D020258), mitochondrial impairment (MESH:D028361), neurodegeneration (MESH:D019636), coronary artery disease (MESH:D003324), obese (MESH:D009765), OX (MESH:D000079225), MCI (MESH:D060825), AD (MESH:D000544), neuroinflammation (MESH:D000090862), blood pressure (MESH:D006973), Cognitive Impairment (MESH:D003072), stroke (MESH:D020521), chronic stress (MESH:D013313), depression (MESH:D003866)
- **Chemicals:** NE (MESH:D009638), Cholesterol (MESH:D002784), glucose (MESH:D005947), tri-glycerides (MESH:D014280), lactate (MESH:D019344), DEHA (MESH:C013966), blood glucose (MESH:D001786), ROS (MESH:D017382), oxygen (MESH:D010100), DHEA (MESH:D003687), Testosterone (MESH:D013739), Estradiol  DHEA (-), estradiol (MESH:D004958), Cortisol (MESH:D006854)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** Val166Met
- **Cell lines:** SH — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_W974), CJ — Homo sapiens (Human), Diffuse large B-cell lymphoma germinal center B-cell type, Cancer cell line (CVCL_UI83)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4549649/full.md

---
Source: https://tomesphere.com/paper/PMC4549649